Analytical method development and validation for the simultaneous estimation of azithromycin and levoflaxacin by RP-HPLC
DOI:
https://doi.org/10.61096/ijpar.v12.iss4.2023.637-646Keywords:
Azithromycin, Levoflaxacin, RP HPLC, Validation ParametersAbstract
A reverse phase high performance liquid chromatographic method was developed for simultaneous estimation of Azithromycin and Levoflaxacine. The chromatographic conditions were successfully developed for the separation of Azithromycin and Levoflaxacine by using ZODIAC –SIL RP C18 column 4.6×100 mm 3.0µm, flow rate was 1.0 ml/min, mobile phase ratio was (75:25 v/v) (KH 2 PO 4 and K 2 HPO 4 ) pH 9, detection wave length was 292 nm. The precision study was precise, robust, and repeatable. LOD value was 2.17 and 6.60, and LOQ value was 0.032 and 0.1125 respectively. Hence the suggested RP-HPLC method can be used for routine analysis of Azithromycin and Levoflaxacin in API and Pharmaceutical dosage form.